BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
575 results:

  • 1. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
    Govind K; Paruk IM; Motala AA
    BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope.
    Giri S; Sahoo J
    World J Gastroenterol; 2024 Mar; 30(12):1670-1675. PubMed ID: 38617746
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence of metastases outside the liver and abdominal lymph nodes on
    Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K
    J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma.
    Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
    Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sleep and Risk of Pancreatic cancer in the UK Biobank.
    Freeman JR; Saint-Maurice PF; Zhang T; Matthews CE; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):624-627. PubMed ID: 38387085
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. TMCO1 regulates cell proliferation, metastasis and EMT signaling through calr, promoting ovarian cancer progression and cisplatin resistance.
    Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prevalence of thyroid diffuse goiter and its association with body mass index and the presence of cysts and nodules in children and adolescents: the Fukushima Health Management Survey.
    Nakahata N; Asano M; Abe N; Ejiri H; Ota H; Suzuki S; Sato A; Tazaki R; Nagamine N; Takahashi C; Yamaya Y; Iwadate M; Matsuzuka T; Ohira T; Yasumura S; Suzuki S; Furuya F; Shimura H; Suzuki S; Yokoya S; Ohto H; Kamiya K
    Endocr J; 2024 Apr; 71(4):383-393. PubMed ID: 38369332
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
    Li W; Huang L; Qi N; Zhang Q; Qin Z
    BMC Genomics; 2024 Feb; 25(1):183. PubMed ID: 38365611
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Epigenetic therapeutic strategies in pancreatic cancer.
    Orlacchio A; Muzyka S; Gonda TA
    Int Rev Cell Mol Biol; 2024; 383():1-40. PubMed ID: 38359967
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ovarian cancer survival in sub-Saharan Africa by human development index and histological subtypes: A population-based registry study.
    Gizaw M; Parkin DM; Stöter O; Bukirwa P; Seife E; Chesumbai G; Korir A; Liu B; Manraj SS; Nda G; Somdyala NIM; Kantelhardt EJ
    Int J Cancer; 2024 Jun; 154(11):1911-1919. PubMed ID: 38339849
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Closing the diagnostic gap: Liquid biopsy potential to transform ovarian cancer outcomes in sub-Saharan Africa.
    Kokori E; Olatunji G; Ogieuhi IJ; Muogbo I; Isarinade D; Ukoaka B; Ajayi I; Ezenwoba C; Samuel O; Nurudeen-Busari H; Olawade DB; Aderinto N
    Medicine (Baltimore); 2024 Feb; 103(5):e37154. PubMed ID: 38306573
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of the Therapeutic Efficacy and Technical Outcomes between Conventional Fixed Electrodes and Adjustable Electrodes in the Radiofrequency Ablation of Benign Thyroid Nodules.
    Shin JH; Seo M; Lee MK; Jung SL
    Korean J Radiol; 2024 Feb; 25(2):199-209. PubMed ID: 38288899
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic indicators in pituitary adenoma surgery: a comprehensive analysis of surgical outcomes and complications.
    Riley G; Scheyer N; Klein M; Merlot I; Guerci B; Jeanbert E; Demarquet L
    Front Endocrinol (Lausanne); 2023; 14():1327404. PubMed ID: 38274233
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Establishment and Verification of a Nomogram Model for Predicting the Overall Survival of Medullary Thyroid Carcinoma: An Analysis Based on the SEER Database.
    Wang W; Wang X; Che G; Qiao J; Chen Z; Liu J
    Curr Oncol; 2023 Dec; 31(1):84-96. PubMed ID: 38248091
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
    Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
    Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic cancer: A Systematic Review and Meta-Analysis.
    Nichetti F; Rota S; Ambrosini P; Pircher C; Gusmaroli E; Droz Dit Busset M; Pusceddu S; Sposito C; Coppa J; Morano F; Pietrantonio F; Di Bartolomeo M; Mariani L; Mazzaferro V; de Braud F; Niger M
    JAMA Netw Open; 2024 Jan; 7(1):e2350756. PubMed ID: 38190183
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical impact of unsuccessful subcutaneous administration of octreotide LAR instead of intramuscular administration in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
    Krishnan T; Safro M; Furlanetto DM; Gill S; Solar Vasconcelos JP; Stuart HC; Martineau P; Loree JM
    J Neuroendocrinol; 2024 Jan; 36(1):e13360. PubMed ID: 38088132
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Long-term quality of life is better after laparoscopic compared to open pancreatoduodenectomy.
    Dagorno C; Marique L; Korrel M; de Graaf N; Thouny C; Renault G; Ftériche FS; Aussilhou B; Maire F; Lévy P; Rebours V; Lesurtel M; Sauvanet A; Dokmak S
    Surg Endosc; 2024 Feb; 38(2):769-779. PubMed ID: 38052888
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
    Xu T; Zhu C; Song F; Zhang W; Yuan M; Pan Z; Huang P
    BMC Cancer; 2023 Nov; 23(1):1131. PubMed ID: 37990304
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 29.